Canopy Biosciences
Canopy Biosciences is a biotechnology company specializing in research tools for gene editing, molecular biology, and personalized medicine. Founded in 2016 and headquartered in St. Louis, Missouri, the company offers a range of products and services designed to enhance scientific discovery in biomedical research. Its gene editing technology, known as TUNR, facilitates targeted modifications in the genome by inserting polyA tracks into specific coding regions, which reduces mRNA levels and subsequently suppresses protein expression. This innovative approach supports researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, advancing the fields of genetic engineering and gene expression analysis. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Core Diagnostics
Acquisition in 2019
Core Diagnostics is a Clinical laboratory focused on Next Generation Diagnostics for disease stratification and therapy selection. We are focused on bringing the most advanced testing techniques and expertise to India. We aim to become the destination for all your high-end diagnostic needs.
Zellkraftwerk
Acquisition in 2019
Zellkraftwerk GmbH, based in Leipzig, Germany, specializes in the development and manufacturing of workflow solutions for cytometry focused on cells and tissues. The company provides a comprehensive range of products and research services, including instruments, consumables, and software that leverage chip cytometry technology. Zellkraftwerk's offerings enable clients to analyze over 100 markers per cell, thereby enhancing capabilities in areas such as sample preparation, biobanking, multiplexed protein and biomarker analysis, and data mining. As of April 2019, Zellkraftwerk operates as a subsidiary of Canopy Biosciences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.